Skip to content

Author

B. Karikalan

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Sep 2026

Targeting TP53 in triple-negative breast cancer: Molecular pathogenesis, therapeutic implications, and emerging pharmacological strategies.

Triple-negative breast cancer (TNBC) remains a highly aggressive and therapeutically challenging subtype, defined by the absence of oestrogen, progesterone, and HER2 expression. Tumour Protein 53 (TP53) mutations represent the most frequent genetic alteration, occurring in over 80% of cases and driving tumour initiatio...

B. Karikalan, Ye Htut Linn, Shiueh-Lian Mok · 0 citations
Open access Aug 2026

Targeting Apoptosis and Autophagy in Cancer: Molecular Mechanisms, Therapeutic Modulators, Clinical Advances, and Future Perspectives

Cancer is a leading cause of mortality globally. Apoptosis, a highly selective and natural mechanism of programmed cell death, and autophagy, a physiological state at the cellular level that eliminates misfolded proteins and aberrant organelles, are both related. Apoptotic cell death occurs through caspase activation,...

S. Chakravarthi, B. Karikalan, Prarthana Kalerammana Gopalakrishna et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.